Liver transplantation for early-stage hepatocellular carcinoma: An intention to treat analysis
✍ Scribed by M.C. Dezza; V. Corno; A. Lucianetti; M. Zambelli; M. Guizzetti; D. Pinelli; A. Sonzogni; G. Gaffuri; R. Viganò; L. Pasulo; M. Di Giorgio; M.G. Lucà; M. Colpani; G. Verga; S. Fagiuoli; M. Colledan
- Book ID
- 119228677
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 79 KB
- Volume
- 39
- Category
- Article
- ISSN
- 1590-8658
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We previously reported encouraging results of down-staging of hepatocellular carcinoma (HCC) to meet conventional T2 criteria (one lesion 2-5 cm or two to three lesions <3 cm) for orthotopic liver transplantation (OLT) in 30 patients as a test of concept. In this ongoing prospective study, we analyz
Liver transplantation is proposed as the best therapy for early hepatocellular carcinoma in cirrhotic patients. However, the confrontation with the results obtained by surgical resection has never been done on an intention-to-treat basis. Between 1989 and 1997, 164 out of 1,265 patients with hepatoc
Single-center studies have shown acceptable long-term outcomes following orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC) when tumors are within the Milan criteria. However, the overall survival and waiting list removal rates have not been described at a national level with